Taro Announces Final Results of Its Tender Offer

18:27 EST 19 Dec 2019 | Businesswire
This article has expired, however you can still download the PDF.
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today announced the final results of its modified “Dutch auction” tender offer to repurchase up to $225 million in value of its ordinary shares, nominal (par) value NIS ...

Other Sources for this Article

William J. Coote
VP, Treasurer
(914) 345-9001


More From BioPortfolio on "Taro Announces Final Results of Its Tender Offer"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...